Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 832.3B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.3/5 136.19B 16.93 -0.38% 6.27%
Anika Therapeutics (ANIK)
4.3/5 835.82M 25.08 1.03% 20.82%
Gilead Sciences (GILD)
4.3/5 107.9B 9.04 0.36% 2.34%
PDL BioPharma (PDLI)
4.2/5 503.84M 7.04 -4.23% -7.58%
Cambrex (CBM)
4.2/5 1.75B 19.58 0.09% 15.99%
Biogen Inc (BIIB)
4.1/5 66.61B 20.91 0.09% 1.88%
Celgene (CELG)
4.1/5 112.49B 44.83 0.74% 31.49%
Innoviva (INVA)
4.0/5 1.48B 17.67 -0.22% 20.24%
China Biologic Products (CBPO)
4.0/5 2.45B 23.47 -0.22% -27.98%
Regeneron Pharma (REGN)
4.0/5 46.07B 43.45 -0.44% 5.44%
Emergent Biosolutions (EBS)
3.9/5 1.55B 26.26 1.24% 35.19%
Enzo Biochem (ENZ)
3.7/5 486.51M 14.55 -1.97% 103.7%
Illumina (ILMN)
3.7/5 29.24B 39.49 -3.82% 12.31%
Alexion Pharma (ALXN)
3.6/5 31.9B 61.83 -0.57% 12.26%
Repligen (RGEN)
3.6/5 1.5B 85.80 -4.99% 36.28%
Heska (HSKA)
3.6/5 646.59M 45.59 -4.93% 64.08%
BioTechne Corporation (TECH)
3.5/5 4.53B 62.58 -0.26% 12.05%
MiMedx (MDXG)
3.5/5 1.38B 66.47 -7.61% 41.43%
ANI Pharma (ANIP)
3.5/5 592.63M 108.78 0.42% -24.91%
Exelixis (EXEL)
3.4/5 8.23B 128.79 -11.28% 64.34%
Qiagen (QGEN)
3.4/5 7.26B 97.55 0.25% 16.28%
Myriad Genetics (MYGN)
3.3/5 2.3B 105.59 2.24% 55.93%
Integra LifeSciences (IART)
3.3/5 3.77B 59.67 -5.69% 12.65%
Ligand Pharma (LGND)
3.3/5 2.86B 376.53 0.3% 17.08%
Osiris Therapeutics (OSIR) 3.1/5 188.17M 78.00 0.93% 12.97%
AMAG Pharma (AMAG)
3.1/5 651.07M - -5.45% -24.92%
Horizon Pharma (HZNP)
2.9/5 2B - 4.05% -36.59%
Genomic Health (GHDX)
2.8/5 1.07B - -1.43% 7.42%
Vertex Pharma (VRTX)
2.8/5 38.34B 148.29 -1.27% 66.9%
Incyte (INCY)
2.8/5 24.24B - -6.38% 24.58%
Bio-Rad Labs (BIO.B)
2.8/5 6.76B 456.02 -0.15% 41.86%
MannKind (MNKD)
2.6/5 203.08M 1.48 -13.16% -35.57%
Alkermes (ALKS)
2.6/5 7.74B - -3.17% 1.59%
Retrophin (RTRX)
2.6/5 871.35M - -0.65% 2.08%
Acorda Therapeutics (ACOR)
2.5/5 1.1B - 1.74% -14.04%
NeoGenomics (NEO)
2.4/5 866.92M - 1.85% 32.17%
Seattle Genetics (SGEN)
2.4/5 7.49B - -0.78% -6%
Organovo (ONVO)
2.4/5 213.31M - -1.01% -50.38%
Vanda Pharmaceuticals (VNDA)
2.4/5 845.58M - 2.2% 10.65%
EXACT Sciences (EXAS)
2.4/5 5.36B - 8.17% 127.98%
Kamada (KMDA)
2.4/5 171.18M - 2.15% -4.23%
Sinovac Biotech (SVA) 2.4/5 392.86M - 0.58% 18.76%
BioMarin Pharma (BMRN)
2.4/5 16.37B - 3.23% -2.52%
Array BioPharma (ARRY)
2.4/5 2.2B - 0.27% 210.14%
Regenxbio (RGNX)
2.3/5 909.9M - -5.2% 93.63%
Galapagos (GLPG)
2.2/5 5.09B - -0.55% 39.82%
Keryx Biopharma (KERX)
2.2/5 821.75M - -4.92% 32.38%
Arna Pharma (ARNA)
2.1/5 984.82M - 3.21% 44.2%
CytomX Therapeutics (CTMX)
2.1/5 647.76M - -0.06% 11.96%
Momenta Pharma (MNTA)
2.1/5 1.25B - 1.18% 44.48%
Intercept Pharma (ICPT)
2.1/5 1.85B - -35.68% -62.95%
Prothena (PRTA)
2.1/5 2.49B - 0.2% 3.55%
Amarin (AMRN)
2.1/5 877.37M - 1.23% 11.9%
bluebird bio (BLUE)
2.1/5 5.83B - -3.23% 79.62%
Acadia Pharma (ACAD)
2.1/5 4.61B - 1.65% 7.46%
Cytokinetics (CYTK)
2.1/5 762.07M - 0.35% 63.24%
Fortress Biotech (FBIO)
2.0/5 228.38M - -1.35% 47.65%
Alnylam Pharma (ALNY)
2.0/5 10.36B - 49.74% 50.59%
Lexicon Pharma (LXRX)
2.0/5 1.35B - -3.28% -33.49%
Cellectis (CLLS)
2.0/5 989.86M - -2.01% 9.27%
Merrimack Pharma (MACK)
2.0/5 197.86M 4.53 -2.13% 138.46%
Inovio Pharma (INO)
1.9/5 567.53M - 2.5% -35.26%
NewLink Genetics (NLNK)
1.9/5 316.53M - -9.1% -14.61%
Geron (GERN)
1.9/5 347.09M - -1.82% -1.82%
Pieris Pharma (PIRS)
1.9/5 229.08M - -2.76% 212.43%
Halozyme Therapeutics (HALO)
1.9/5 2.36B - 0.36% 38.79%
Juno Therapeutics (JUNO)
1.9/5 4.43B - 1.1% 49.92%
Blueprint Medicines (BPMC)
1.9/5 2.44B - -0.95% 117.76%
Idera Pharma (IDRA)
1.9/5 338.17M - 0 -19.2
Kite Pharma (KITE)
1.9/5 10.29B - 0.23% 228.57%
Intellia Therapeutics (NTLA)
1.8/5 929.91M - 8.29% 42.77%
Editas (EDIT)
1.8/5 966.61M - 6.93% 58.02%
Acceleron Pharma (XLRN)
1.8/5 1.54B - -11.55% -11.82%
Evogene (EVGN) 1.8/5 110.96M - 0.47% -33.86%
Celldex Therapeutics (CLDX)
1.8/5 315.72M - 5.14% -30.55%
Amicus Therapeutics (FOLD)
1.8/5 2.6B - 6.88% 91.48%
Arbutus Biopharma (ABUS)
1.8/5 385.19M - 15.93% 65.4%
SANGAMO THERAP (SGMO)
1.8/5 1.2B - -6.78% 175%
AVEO Pharmaceuticals (AVEO)
1.8/5 439.51M - -4.51% 300%
Peregrine Pharma (PPHM)
1.8/5 140.7M - 0.96% 9.91%
Adaptimmune Therapeutics (ADAP)
1.7/5 595.39M - -6.38% 11.38%
Curis (CRIS)
1.7/5 260.57M - -10.8% -36.69%
Dynavax Technologies (DVAX)
1.7/5 1.24B - -1.2% 79.67%
Spark Therapeutics (ONCE)
1.7/5 3.18B - 2.8% 41.4%
Aduro BioTech (ADRO)
1.7/5 820.74M - -3.14% -25.72%
Abeona Therapeutics (ABEO)
1.7/5 652.65M - -9.39% 137.68%
Mesoblast (MESO)
1.7/5 467.62M - 1.3% 23.76%
Athersys (ATHX)
1.7/5 281.36M - 7.14% 26.24%
Five Prime Therapeutics (FPRX)
1.7/5 1.02B - -3.78% -35.18%
Stemline Therapeutics (STML)
1.7/5 276.27M - 2.33% 3.97%
Adverum (ADVM) 1.7/5 153.67M - -1.45% -19.05%
MyoKardia (MYOK)
1.7/5 1.67B - 1.01% 166.84%
ZIOPHARM Oncology (ZIOP)
1.6/5 860.29M - -1.91% 7.12%
Compugen (CGEN)
1.6/5 186.63M - 5.71% -45.67%
Merus (MRUS)
1.6/5 327.91M - 13.51% 56.85%
Uniquire (QURE)
1.6/5 243.73M - 13.11% 18.86%
Immunomedics (IMMU)
1.6/5 1.54B - 1.87% 250.76%
Agenus (AGEN)
1.6/5 408.82M - -0.24% -40.58%
Fate Therapeutics (FATE)
1.5/5 163.18M - -3.06% 19.77%
Coherus Biosciences (CHRS)
1.5/5 644.56M - 1.18% -57.17%
Achillion Pharma (ACHN)
1.5/5 560.72M - 9.89% -52.7%
Paratek Pharma (PRTK)
1.5/5 688.48M - 0.41% 83.1%
MediciNova (MNOV)
1.4/5 206.2M - 10.95% -12.96%
Alder BioPharma (ALDR)
1.4/5 707.61M - 3.33% -68.06%
OncoMed Pharma (OMED)
1.4/5 165.95M - -3.46% -62.9%
Syndax Pharma (SNDX)
1.4/5 253.53M - -4.22% -14.66%
Vtv Therapeutics (VTVT)
1.4/5 190.31M - -1.17% -17.85%
Beigene (BGNE)
1.4/5 3.4B - 2.86% 179.24%
Novavax (NVAX)
1.4/5 315.46M - 3.57% -48.67%
MIRAGEN THERAP (MGEN)
1.4/5 192.06M - 2.86% 15.32%
Wave Life Sciences (WVE)
1.4/5 635.71M - -8.52% -35.9%
Reata Pharma (RETA)
1.4/5 825.39M - -0.41% 37.45%
Revance (RVNC)
1.4/5 750.45M - -1.23% 37.56%
Seres Therapeutics (MCRB)
1.4/5 677.35M - 10.49% 25%
Epizyme (EPZM)
1.4/5 1.27B - -5.04% 74.74%
CRISPR THERAPTC (CRSP)
1.4/5 772.05M - -0.52% 34.63%
Ascendis Pharma (ASND)
1.3/5 901.62M - 16.3% 74.43%
The Medicines Company (MDCO)
1.3/5 2.54B - 2.4% -12.39%
Nymox Pharmaceutical (NYMX)
1.3/5 200.57M - 0.52% 14.08%
Intra-Cellular Therapies (ITCI)
1.3/5 835.84M - -4.5% -54.5%
Clearside Biomedical (CLSD)
1.3/5 206.49M - 9.21% -40.63%
NantKwest (NK)
1.3/5 429.77M - -7.56% -30.47%
Cara Therapeutics (CARA)
1.3/5 429.42M - -3.26% 78.17%
Selecta Biosciences (SELB)
1.2/5 435.75M - 2.95% 27.71%
Advaxis (ADXS)
1.2/5 194.24M - -7.68% -57.69%
KADMON HOLDINGS (KDMN)
1.2/5 183.54M - 18.12% -56%
Insmed (INSM)
1.2/5 2.21B - 0.74% 93.09%
Trevena (TRVN)
1.1/5 149.24M - -1.99% -64.86%
Sarepta Therapeutics (SRPT)
1.1/5 3.03B - -3.54% -21.89%
Nabriva Therapeutics (NBRV)
1.1/5 227.26M - -4.51% 15.57%
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Addex Therapeutics (ADDXF) - 29.6M - 0 -19.71
Bionovo (BNVIQ) - 0.02M - N/A N/A
Oncolytics Biotech (ONCYF) - 76.01M - 0.54% 100.36%
Protalix Biotherapeutics (PLX) - 78.71M - -9.52% -1.58%
Gliatech (GLIAQ) - 0M - N/A N/A
Rexahn Pharma (RNN) - 68.59M - 6.03% 12.64%
Cellcyte Genetics (CCYG) - 0.12M - 0 0
VIA Pharma (VIAP) - 0.04M - 0 -75
Dyadic International (DYAI) - 44.34M - 3.55% 3.55%
Invo Bioscience (IVOB) - 38.15M - 12.97% -18.18%
Williston Holding (WHCA) - 3.14M - 0 627.27
Vital Therapies (VTL) - 200.49M - 4.26% -19.28%
Myrexis (MYRX) - 1.76M - 0 -35.44
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 123.68M - 2.29% -43.89%
BioForce Nanosciences (BFNH) - 1.34M - 0 307.69
Immune Therapeutics (IMUN) - 10.4M - -3.13% -65.93%
BioTime (BTX) - 323.09M - -1.75% -26.32%
Panacos Pharma (PANC) - 0.01M - 0 -100
Protein Polymer (PPTIQ) - 0.06M - N/A N/A
Wowi (WOWU) - 5.7B - 0 36.67
Genitope (GTOPQ) - 0.06M - N/A N/A
Viralytics (VRACY) - 169.01M - 0 1.44
Unigene Laboratories (UGNEQ) - 0.07M - 0 0
Taxus Cardium Pharma (CRXM) - 2.17M - -7.36% -44.07%
Nicox (NICXF) - 280.04M - 0 4.04
Interleukin Genetics (ILIU) - 0.92M - -20% -97.65%
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
DBV Tech (DBVT) - 2.14B - 0.7% 15.76%
International Stem Cell Corp (ISCO) - 7.22M - 20.13% -2.63%
Theratechnologies (THERF) - 448.04M - 1.85% 175.79%
Bellus Health (BLUSF) - 20.73M 108.33 1.88% 69.27%
Pathfinder Cell (PFND) - 2M - -25% 50%
Provectus Biopharma (PVCT) - 9.15M - -7.69% -77.98%
Regenicin (RGIN) - 10.71M - -2.78% 75%
Health Discovery (HDVY) - 1.09M - 0 -85.19
ZYTO Corp (ZYTO) - 0.91M - 0 13.04
Polymedix (PYMXQ) - 0M - N/A N/A
Dendreon (DNDNQ) - 5.4M - N/A N/A
Amarillo (AMAR) - 6.06M - -3.57% 28.57%
Ultragenyx Pharma (RARE) - 2.23B - -1.57% -28.15%
Nutra Pharma (NPHC) - 0.76M - 0 -100
ImmunoCellular Therapeutics (IMUC) - 5.17M - -1.41% -92.88%
Advanced Life Sciences (ADLS) - 0M - 0 -100
Avax Technologies (AVXT) - 2.62M - 100% -33.33%
Arbutus Biopharma (ABUS)
- 385.19M - 15.93% 65.4%
Biocurex (BOCX) - 0M - N/A N/A
Quick-Med Technologies (QMDT) - 0.67M - 0 63.64
Genmab (GNMSF) - 13.71B 77.86 -0.44% 42.18%
Redpoint Bio (RPBC) - 0.14M - 100% 100%
Cormedix (CRMD) - 25.04M - 11.9% -82.97%
HUMANIGEN INC (HGEN) - 5.69M - -5% -89.14%
MMRGlobal (MMRF) - 0.23M - 100% -75%
AtheroNova (AHROQ) - 0.12M - 20% -7.69%
Asterias Biotherapeutics (AST) - 157.43M - -1.54% -31.18%
US Stem Cell (USRM) - 6.8M - 0 35.71
YBCC INC (YBAO) - 1.58M - 0 -54.29
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Synvista Therapeutics (SYNI) - 0M 0.00 0 0
Capstone Therapeutics Corp. (CAPS) - 3.26M - -20% -7.69%
Puma Biotech (PBYI) - 3.87B - -0.43% 53.5%
Response Genetics (RGDXQ) - 0.05M - 0 0
Guangzhou Pharma (GZPHY) - 639.8M - 0 -11.98
Clovis Oncology (CLVS) - 3.76B - 2.37% 111.52%
Deltagen (DGEN) - 0.02M - 0 0
Helix Biomedix (HXBM) - 7.85M - 0 0.21
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Starpharma (SPHRY) - 306.67M - 15.24% 92.06%